Regulatory and ClinicalIND Cleared for StudyJul 17, 2026 · 7:02am ET
KLRSKalaris Therapeutics, Inc.
Kalaris Therapeutics Announces Additional Phase 1a Data Presentation for TH103
Company remains on track for Phase 1b/2 study data release in H1 2027.
Regulatory and ClinicalIND Cleared for StudyJul 17, 2026 · 7:02am ET
KLRSKalaris Therapeutics, Inc.+33.0%
Kalaris Therapeutics Announces Additional Phase 1a Data Presentation for TH103